Diagnostic Landscape Review: How Changes in Technology, Drug Development Portfolio & Global Regulatory Landscape are Altering the Diagnostic Testing Landscape

Time: 1:50 pm
day: Day 1 Track C PM


  • As the promise of precision medicine has come to fruition, there is increased attention on diagnostic tests for use in drug development, registration/approvals and for routine patient and health management
  • This talk will focus on the changing landscape for diagnostics providing awareness for emerging challenges globally (IVDR) as well as challenges in implementing companion diagnostics outside of oncology from a regulatory, laboratory, IVD sponsor as well as early commercial considerations
  • The future of diagnostics for drug development and patient care are starting to emerge and as an industry we need to be looking forward on what we need to do today to be prepared for what the future state of diagnostics will be